Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • JSThompson
    Junior Member
    • Jun 2017
    • 4

    #1

    Pindel and GATK AD Concordance

    I was hoping to get some advice on working with the AD field for variants in VCFs produced by Pindel and Pindel2VCF.

    My lab has a variant calling pipeline that uses GATK's UnifiedGenotyper for calling SNVs and small Indels, as well as using Pindel to call deletions and short insertions. As part of our VCF filtering, we remove variants with an Variant Allele Fraction below a certain threshold. However, it has been brought to my attention by other members of the lab that when Pindel and UnifiedGenotyper call the same variant, they have different AD values and so different VAF values (I'm not sure if it's relevant, but the AD for UnifiedGenotyper is the same as found in IGV).

    Normally the difference is small enough that it doesn't affect our filtering, but there have been some cases where a variant called by both branches of the pipeline has an VAF greater than our cutoff threshold in one VCF, but has an VAF lower than threshold in the other VCF. To avoid this issue, which value for AD should I be using for calculating VAF? The AD from UnifiedGenotyper, or the AD from Pindel?

    Thanks in advance for any suggestions.
  • JSThompson
    Junior Member
    • Jun 2017
    • 4

    #2
    I've also posted this thread on BioStars (https://www.biostars.org/p/256882/)

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-22-2026, 11:13 AM
    0 responses
    27 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 10:48 AM
    0 responses
    20 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    36 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    43 views
    0 reactions
    Last Post SEQadmin2  
    Working...